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It  has  recently  been  observed  that  many  weeks  after  injection  of  small 
amounts of antigen, removal of antibody from the circulation results in a  spe- 
cific, secondary-type, antibody response (1,  2). This observation suggests that 
a  dynamic  equilibrium  between  persisting  immunogen  and  circulating  anti- 
body regulates  the immune response  (3),  and further,  that immunocompetent 
cells can capture antigen in the presence of excess circulating antibody. It has 
been postulated that immunocompetent cells by virtue of their large number of 
receptors  might  have  an  increased  avidity for  antigen  as  compared  with  an 
equal number of antibody molecules in solution (4). 
The murine plasmacytoma MOPC 315  secretes an IgA which binds dinitro- 
phenyl  (DNP) 1 with  moderate  affinity  (5).  In the  experiments  which follow, 
we describe the use of these myeloma cells as a  model in which the interaction 
of immunoglobulin  (Ig)  on cell  surfaces with  antigen  can be studied  in a  ho- 
mogenous cell  preparation.  Using  this  system we have  been  able  to  measure 
the binding affinities of cell surface Ig for univalent and for multivalent DNP 
conjugates. 
Materials and Methods 
Source and  Preparation of Cells.--The  following lines of  murine  plasmacytomas  were 
carried by serial transplantation  in female BALB/c mice (Jackson Laboratory, Bar Harbor, 
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1  Abbreviations used in this paper: DNFB, 1-fluro-2,4-dinitrobenzene; DNP, dinitrophenyl; 
DNP-BSA,  dinitrophenylated  bovine  serum  albumin;  EACA,  e-amino-N-caproic  acid; 
PBS, phosphate-buffered saline; SSS, Spinner salt solution. 
THE  JOURNAL OF  EXPERIMENTAL MEDICINE • VOLUME 137,  1973  301 302  BINDING  OF  ANTIGEN  BY  IMMUNOCYTES 
Maine):  (a)  MOPC  315  cells secreting IgA  (obtained from Dr.  M.  Potter, National Insti- 
tutes of Health, Bethesda, Md.);  (b)  LPC  1 cells  secreting IgG2A  (obtained from Dr.  F. 
Hymes, NCI Immunoglobulin Reference Center, Springfield,  Va.), and (c) HP 76 cells secret- 
ing IgM (obtained from Dr. Noel Warner, Hall Institute, Melbourne, Australia). For prepa- 
rations of cell suspensions, the animals were sacrificed  by cervical dislocation 2-4 wk after 
tumor inoculation, and the tumors were removed and finely minced in Spinner salt solution 
(Eagle; SSS; Grand Island Biological Co., Grand Island, N. Y.). The cells were passed through 
a  fine stainless steel mesh, washed twice with 40  ml of SSS, and resuspended in 0.5  ml of 
SSS. Red blood ceils and some nonviable tumor cells were lysed by osmotic shock resulting 
from addition of 4 m] of cold distilled water. After 30 s, physiologic osmolarity was restored 
by the addition of 40 ml of SSS. Viable cells were pelleted by centrifugation and resuspended 
to a  concentration of 7-10  X  l0  G  per ml in phosphate-buffered saline (PBS; 0.15  M  NaCI, 
0.01  M potassium phosphate buffer,  pH 7.3). Viability ranged from 65 to 85% as judged by 
trypan blue exclusion. 
P;~K murine plasmacytoma cells secreting IgG (obtained from Dr.  Kengo Horibata, Saik 
Institute, San Diego,  Calif.)  were carried in Dulbecco's medium with 10%  horse serum, and 
were used after washing three times in 40 ml of SSS. Viability of these cells was over 90% 
as determined by trypan blue exclusion. 
Antigens.--Dinitrophenylated  bovine serum albumin  (DNP-BSA)  was prepared by  the 
reaction of 2,4-dinitrobenzene sulfonic  acid  (Fisher Chemical  Co.,  New  York)  with B SA 
(Pentex  Biochemical,  Kankakee,  Ill.)  at  room  temperature  under  alkaline  conditions as 
described by Eisen, Belman, and Carsten (6). The product was extensively dialyzed against 
0.001 M phosphate buffer (pH 7.3) and its concentration  determined after drying a known vol- 
ume to constant weight at 95°C.  The preparation used had approximately 23  DNP gloups 
per molecule of BSA based upon its absorbancy at 360 nm taking e =  17,500 for DNP-lysine. 
DNP-BSA was radiolabeled by lactoperoxidase-catalyzed  iodination (7) to a specific activity 
of 5-10  X  105 cpm/#g. 
N-2,4-dlnitrophenyl+amlno-N-caproic acid  (DNP-EACA)  was  prepared  by  the  reac- 
tion of 1-fluoro-2,4-dinitrobenzene (DNFB; Eastman Organic Chemicals, Rochester, N. Y.) 
with ~-amino-N-caproic acid  (EACA;  Sigma Chemical Co.,  St. Louis,  Mo.)  under alkaline 
conditions. The  product  was purified by  crystallization from hot  50%  ethanol.  Tritiated 
DNP-EACA  was  prepared  by  the  reaction  of  [aH]DNFB  (Amersham-Searle, Arlington 
Heights, Ill.) with EACA. The product was purified by thin-layer chromatography on silica- 
gel  plates using p-dioxane as  solvent. Details for preparation of these haptens have been 
presented previously (8). Specific activity of the product was 2 X  10 ~ cpm/ng. Goat IgG was 
prepared by salting out with ammonium sulfate, and the dialyzed precipitate was chromato- 
graphed on  DEAE-Sephadex (A-25). 
Antisera.--Antisera  to immunoelectrophoretically pure  mouse or human  IgG were pre- 
pared by weekly injection of goats with 0.5  mg of the respective immunoglobulin in com- 
plete Freund's adjuvant. Serum was collected after 6-10 injections and was demonstrated to 
be specific  for the immunizing antigen by immunoelectrophoresis. Antisera to  mouse IgG 
reacted against mouse K-chains. 
Binding of DNP Conjugates to Cdls.--O.1 ml of myeloma cell suspensions, adjusted to a 
concentration of 7-10 X  106 cells per ml, were incubated with varying concentrations of DNP 
conjugate. Incubation was performed at 27°C. Cells were pelleted at 800 g for 6 min and were 
washed repeatedly with 2 ml of PBS as indicated in text. The amount of cell-bound DNP 
conjugate was calculated from its specific activity and the counts per minute of the washed 
cell pellet. For aH counting, the cell pellet was dissolved in 1 ml of NCS (Amersham-Searle) 
at 37°C for 1 h, and a 0.7 ml aliquant was counted in 10 ml of Liquiflor (New England Nu- 
clear Corp., Boston, Mass.). All assays were performed in duplicate or triplicate tubes. 
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amount bound nonspecifically to  control  murine myeloma cells from the amount bound  to 
a  similar number of MOPC 315 cells under identical conditions. Three different lines (P3K, 
LPC 1, and HP 76) of murine myeloma cells were used as controls and yielded similar results. 
The average association constant (Ko) and the number of binding sites per cell were calculated 
from a Scatchard plot of specific binding of DNP conjugate to MOPC 315 cells. 
RESULTS 
Binding  of  [125I]DNP-BSA  to  Cells.--In  order  to  determine  whether  cell 
surface molecules with specificity for DNP are present on MOPC 315  cells,  the 
binding  of  [~%I]DNP-BSA  to  MOPC  315  was  compared with  its  binding  to 
other myeloma cells whose secreted proteins have no  detectable  rectivity with 
DNP. In addition,  the effect of [125I]DNP-BSA  concentration on the quantity 
of ligand bound was determined. 
As can be seen in Fig.  1, at every ligand concentration studied considerablv 
more [~%I]DNP-BSA was bound to MOPC 315 cells than to control cells (P~K). 
The  ratio  of  [mSI]DNP-BSA bound  by MOPC  315  to  the  amount  bound  to 
control  cells  was greatest  at  low  ligand  concentrations.  The  maximum ratio 
obtained was 8, but at the highest [~2aI]DNP-BSA  concentration it decreased to 
1.7.  Similar results were obtained with either HP 76 or LPC  1 myeloma cells 
as controls. 
The greater binding of DNP-BSA by MOPC 315  as compared with control 
cells could be due to variations in the viability or in the surface area of the dif- 
ferent cell  types used.  Similar results  were obtained,  however,  when  control 
cells of different degrees of viability (by trypan blue exclusion) were employed. 
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1216.  1.  Binding of [I~I]DNP-BSA  to cells.  Similar numbers of MOPC  315  or P3K cells 
were incubated for 10 min with varying concentrations of the conjugate in medium contain- 
ing  5%  BSA.  Amount  of cell-bound  [125I]DNP-BSA  was  determined  after  cells  had  been 
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Furthermore, when the size of the cells was estimated by measuring the smallest 
and largest diameter of 10-20 cells of each type, MOPC 315 cells were found to 
be intermediate in size as compared with the different control cells used. Thus, 
the preferential binding  of [~5I]DNP-BSA by MOPC  315  cells cannot be ex- 
plained by differences in cell  size or viability. 
Faclors Ajfecliug  lhe Bindi~g  of [~2SI]DNP-BSA lo Cells.--The  effect of the 
concentration of protein in the medium, of washing, and of time of incubation 
on the amount of ligand bound to MOPC 315  and to control cells was studied. 
The  effect of protein  in  the  medium  was determined  by performing binding 
studies in the presence of BSA. As can be seen in Fig. 2, the quantity of [mlJ- 
DNP-BSA bound to MOPC 315 or to control cells was markedly decreased by 
increasing the concentration of BSA. It is of note that without BSA nonspecific 
binding was so great that specific binding was completely obscured.  After re- 
ducing nonspecific binding by the addition of 0.05  mg/ml of BSA, a difference 
between  the  binding  to  MOPC  315  and  control  cells became  evident.  With 
increasing  concentration~  of  BSA,  binding  to  control  cells  decreased  further 
but  not  the  binding  to MOPC  315.  Similar results were obtained  when  goat 
IgG was used instead  of BSA.  Since  specific binding  was maximal when  the 
cells  were  incubated  with  50  mg/ml  of  BSA,  all  subsequent  binding  studies 
with  ['~aI]DNP-BSA were performed in  the presence of this concentration  of 
BSA. 
The effect of repeated washing with  PBS  on the binding of [z-~SI]DNP-BSA 
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Fro. 2.  Effect  of  inhibiting  nonspecific  binding  of  [12~I]DNP-BSA  with  BSA.  Similar 
numbers  of  MOPC  315  or  P,~K  cells  were  incubated  with  [12SI]DNP-BSA  (10  -9 M)  for 
10  min.  Incubation  was performed  in presence  of  varying concentration  of BSA.  Amount 
of cell-bound  [125I]DNP-BSA was determined after cells had been washed three times with 
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to cells is illustrated in Fig. 3. There was a marked decrease in the quantity of 
[leSI]DNP-BSA bound to MOPC 315 cells and to control cells as a result of the 
first two washes. Thereafter, continued washing resulted in a  progressive but 
minimal decrease in bound DNP conjugate. Three washes was selected as the 
standard procedure since it removed over 90 %  of [~SI]DNP-BSA bound non- 
specifically to control cells. 
The effect of time of incubation on the quantity of DNP conjugate bound 
to MOPC 315 cells is illustrated in Fig. 4. At room temperature, binding to cells 
occurred rapidly. Within the first 2 rain 60 % of the maximum binding to MOPC 
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Fro. 3. Effect of washing cells on binding  of [leSI]DNP-BSA. Similar numbers of MOPC 
315 or PaK cells were incubated with [12SI]DNP-BSA  for 10 min at 27°C in the presence of 
5% BSA, and the quantity of conjugate remaining bound  to cells was determined  after 
increasing number of washes with 2 ml of PBS.  15] 
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FIG. 4. Effect of time on binding of [I~SI]DNP-BSA  to cells. Similar numbers of MOPC 
315 or PsK cells were incubated with [12SI]DNP-BSA (10-9 M) in the presence of 5% BSA 
for varying periods of time. Amount of ceil-bound [12SI]DNP-BSA  was determined after the 
cells had been washed three times with PBS. 
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315 ceils, and over 90% of maxinmm binding to control cells had taken place. 
Maximum  binding  to  control  cells  took place  within  10  min  but  binding  to 
MOPC 315  cells appeared  to increase  slowly after  the initial  rapid phase.  All 
subsequent experiments were performed with 10 min of incubation. 
Specificity of Binding of [12~I]DNP-BSA to MOPC 315 Cells.--To establish 
that the binding of ['2~I]DNP-BSA to MOPC 315  cells was due to the specific 
interaction  of the DNP  groups to Ig molecules on  the  cell  surface,  attempts 
were made  to  inhibit  binding  with  DNP-EACA  and  with  antisera  to  mouse 
Ig. As can be seen  in Fig. 5,  specific binding of ['2SI]DNP-BSA could be com- 
pletely inhibited  by the univalent  ligand,  DNP-EA('A. On a  per-binding-site 
basis, the smallest ratio of univalent ligand to [1zSI]DNP-BSA required to com- 
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FIG. 5. Inhibitionof specific  binding of [r2~I]DNP-BSA to MOPC 315 cells byDNP-EACA. 
Similar number of MOPC 315 or PaK cells were incubated  with  [I~SI]DNP-BSA (10  -9 M) 
in  the presence of 5%  BSA and  increasing concentrations  of the univalent  ligand  DNP- 
EACA. Inhibition of specific binding was calculated from the formula: 
Specific binding to MOPC 315 cells in presence of DNP-EACA'~ 
1  --  Specific binding to MOPC 315 c~s in at]senc~(ff-~'P-EAC~/"  X  100. 
pletely inhibit  the binding of [t2'~I]I)NP-BSA was 500  to  1,  based  on an  esti- 
mated 23 DNP groups conjugated to each molecule of BSA. 
Specific  binding  of  [~2~I]DNP-BSA was  also  completely  inhibited  by prior 
incubation of MOP(; 315 cells with goat antisera  to mouse K-chains which are 
present  in the IgA protein  secreted by MOPC 315  (5). As can be seen in Fig. 
6,  there  is  a  relationship  between  the  quantity  of ['2SI]DNP-BSA added  and 
the  percent  inhibition.  At  the  lowest  concentration  of  ['~I]DNP-BSA  used, 
specific binding was completely inhibited. If higher concentrations of [mI]DNP- 
BSA were employed, less inhibition  was observed.  Under identical  conditions 
goat antihuman IgG had a minimal inhibiting effect on specific binding. These 
experiments  indicate  that  specific  binding  of  [12SI]DNP-BSA  to  MOPC  315 
cells is between  the DNP group and specific Ig molecules on the cell  surface. J.-C.  BYSTRYN~  G.  W.  SISKIND,  AND  J.  W.  UHR  307 
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FIG. 6.  Inhibition of specific binding of [t25IIDNP-BSA  by antisera to mouse  Ig.  Similar 
number  of MOPC 315 or control cells were incubated with 1 ml of goat antimouse Ig or goat 
antihuman  IgG for  10 min  at  27°C. After one wash  with PBS,  cells were incubated with 
varying concentrations  of [125I]DNP-BSA. Inhibition of specific binding was calculated from 
the formula: 
Specific binding to MOPC 315 cells in presence of goat antisera~ 
1  --  Specific binding to MOPC 315 cells in absence of goat antisera] 
×  100. 
Association Constant  for Binding of [125I]DNP-BSA to MOPC 315 Cells.--The 
average  association  constant  (Ko)  for  the  interaction  of  [125I]DNP-BSA  to 
MOPC  315  cells was calculated from the specific binding determined at differ- 
ent  concentrations of conjugate.  The  experiments were  conducted under  con- 
ditions which had been previously determined to maximize specific binding. 
A Scatchard plot of the results of a representative experiment is shown in Fig. 
7.  The  average association constant  was calculated from the reciprocal of the 
free  hapten  concentration  at  which  50%  saturation  of  binding  sites  was  at- 
tained.  In  four  independent  experiments  the  values  calculated  for  Ko  were 
6.2,  7.2,  7.8,  and  13  X  107 L/M  (average Ko  =  8.5  X  l0  T L/M).  Since DNP- 
BSA is a multivalent ligand, each molecule could potentially interact with more 
than one anti-DNP  binding site on the MOPC  315  cell. For this reason it was 
not possible to calculate the exact number of binding sites. However, if it is as- 
sumed  that  the number  of binding sites is equal  to or greater than  the  maxi- 
mum number of DNP-BSA molecules bound per cell, then  the minimum num- 
ber  of  binding  sites detected  in  the  four  above  experiments  averaged  84,000 
sites per cell. 
Binding  of Univalent DNP Conjugate to MOPC 315 Cells.--To evaluate  the 
effect of antigen valence on its binding to cell surface receptors, the binding of 
the univalent ligand DNP-EACA was compared with  that  of the multivalent 
ligand  DNP-BSA.  Specific binding  of  [aH]DNP-EACA  to  MOPC  315  could 
be  demonstrated  in  experiments  similar to  those  described  above  using  [12,~]_ 
DNP-BSA. Fig. 8 illustrates the results of a  representative experiment in which 
the  binding of various concentrations  of  [aH]DNP-EACA  to  MOPC  315  and 308  BINDING  OF  ANTIGEN  BY'  IMMUNOCYTES 
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FIG. 7.  Scatchard plot  of  binding of  [12~I]DNP-BSA  to  MOPC  315  cells,  r  is  moles  of 
conjugate bound per MOPC 315 cell,  and c is the free conjugate concentration. Number of 
binding sites per cell  (n)  is calculated by extrapolation of binding curve to its interception 
with abscissa. 
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FIG. 8.  Binding of [aH]DNP-EACA to MOPC  315  or PaK cells.  Similar numbers of cells 
were incubated for 10 min at 27°C with varying concentrations of the conjugate. Amount of 
cell-bound  [aH]DNP-EACA  was  determined  after  cells  had  been washed  two  times  with 
2 ml of PBS. 
to control cells was compared.  It can be seen that at every ligand concentration 
employed,  there  was  more  binding  to  MOPC  315  cells  than  to  control  cells. 
The ratio of moles [~H]DNP-EACA  bound by MOPC  315  cells to moles bound 
to  control  cells  was  greatest  at  low  ligand  concentration,  where  a  ratio  of  5 
was observed, and decreased to  1.4 at the highest concentration of ligand used. .]'.-C.  BYSTRYN~  G.  W.  SISKIND,  AND  J.  W.  UHR  309 
Interaction between the DNP conjugate and cells was rapid.  85 % of maximal 
binding occurred within 5 rain at 27°C. The rate of the reaction was tempera- 
ture dependent, only 50 % of maximal binding occurring within 5 min at 4°C. 
Washing the cells was found to have a profound effect on the specific binding 
of [SH]DNP-EACA.  As can be seen in  Fig. 9, the amount of ligand bound to 
MOPC  315  decreased by 40-90%  with each wash cycle. Nonspecific binding 
of  [3H]DNP-EACA  to  control  cells  did  not  decrease  significantly  after  the 
second wash. 
The presence of protein  in  the  incubation  mixture  was found  to  decrease 
greatly both the total and specific binding of [~H]DNP-EACA to MOPC 315. 
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FI6. 9. Effect of washing cells on binding of [3H]DNP-EACA. Similar number of MOPC 
315 or PaK cells were incubated for 10 rain at 27°C, and the quantity of conjugate remaining 
bound to cells was determined after increasing number of washes with 2 ml of PBS. 
Specific binding in the presence of 5 % BSA was reduced by 85-94%. By con- 
trast, it will be recalled that BSA is required for specific binding of [125I]DNP- 
BSA to become evident. 
Since  DNP-EACA  is  a  small  molecule,  it  is possible  that  its  intracellular 
penetration  during  incubation  falsely  elevated  the  apparent  binding  of  the 
conjugate to the cell surface. This possibility was made unlikely by the finding 
that over 93 % of the specific binding of [3H]DNP-EACA to MOPC 315  could 
be inhibited  by prior incubation  of the cells with goat antimouse Ig but not 
with goat antihuman  Ig. This experiment indicates  the binding of [~H]DNP- 
EACA to MOPC 315 cells is a surface phenomenon and together with the data 
presented above, indicates that the binding is to an Ig molecule located on the 
cell surface. 
Association Constant of [3H]DNP-EACA to MOPC 315.--The average asso- 
ciation  constant  for  the  specific binding  of  [3H]DNP-EACA  to  MOPC  315 
cells was determined  as previously described  for [125I]DNP-BSA,  except  that 310  BINDING  OF  ANTIGEN  BY  IMMUNOCYTES 
BSA was omitted from the medium. It is difficult  to wash out nonspecifically 
bound  DNP-EACA  without  significantly  decreasing  the  amount  of  ligand 
bound specifically.  For  this  reason  the studies  were  conducted with  the  cells 
washed one or two times.  It was found that washing had  little  affect on the 
average  association  constant  of  the  DNP-EACA remaining  bound  to  cells, 
while  the actual number of molecules bound was markedly decreased. 
A  Scatchard plot  of  the results of a  representative experiment  is shown in 
Fig.  10.  After one wash the Ko's calculated for five  independent  experiments 
were 1.6, 2.1, 2.3, 4.1, and 4.25  X  10 ~  L/M, an average of 2.8 X  10  ~ L/M. The 
average number of molecules bound per  cell  was  1.1  X  10  r.  After two wash 
cycles the average number of molecules bound per cell decreased approximately 
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l:m. 10. Scatchard plot of binding of [aH]DNP-EACA  to MOPC 315 cells, r is moles of 
conjugate bound per MOPC 315 cell, and c is the free conjugate concentration. 
4-fold, whereas the calculated Ko was unchanged. Thus, in two separate experi- 
ments, the K,.'s after two washes were 2.7 and 2.8 X  105 L/M, and the average 
number of molecules bound per cell was 2.9 )<  106. The results of these experi- 
ments indicate that the binding affinity of MOPC 315 cells for univalent DNP 
conjugates is approximately 300 times less than for the multivalent ligand by 
direct  measurement of the  average association constants. 
The value calculated for the association constant of the reaction of cell sur- 
face Ig with  [aH]DNP-EACA is considerably lower  than  that determined  for 
the reaction between the Ig secreted by these cells and this ligand. Equilibrium 
dialysis studies carried out by Dr. Young Tai Kim  (Department of Medicine, 
Cornell University Medical  College)  on the binding of [3H]DNP-EACA to Ig 
secreted by the MOPC 315  line  used in  these experiments  yielded a value of 
1.6 X  107 L/M for the association constant and a Sip's heterogeneity index of 
1.03. These values are in agreement with those previously reported for the Ig 
produced by this  tumor  (5).  The  reason for the difference in  the  association 
constants determined for the free as compared with the surface Ig is not known. 
If it is assumed  that  the  surface Ig molecule has binding properties  identical J.-C.  BYSTRYN,  G.  W.  SISKIND,  AND  J.  w.  UPIR  311 
with those of the free Ig secreted by that cell,  then the above data imply that 
there is an overestimate in the number of binding sites per cell when the meas- 
urements are carried out using the univalent ligand.  Such an error in binding 
site concentration is not unlikely under conditions where low affinity interac- 
tions which are difficult to distinguish from nonspecific binding are being inves- 
tigated. 
Displacement of  Univalent and Multivalent DNP Ligands  Bound  to MOPC 
315.--In order to explore further the binding affinity of cell  surface receptors 
for a multivalent as compared to a  univalent ligand,  the displacement rate of 
univalent and multivalent DNP conjugates bound to MOPC 315  was studied. 
In these experiments similar numbers of MOPC  315  or control  cells were in- 
cubated  with  the  univalent  ligand  [3H]DNP-EACA  or with  the  multivalent 
ligand [mSI]DNP-BSA at concentrations equimolar with respect to DNP groups. 
After allowing sufficient  time for maximum binding  to  occur,  unlabeled  uni- 
valent ligand (DNP-EACA) was added in sufficient amount so as to achieve a 
100-fold molar excess with respect to DNP groups. The quantity of radioactive 
conjugate remaining bound to cells after various time intervals was determined. 
As can be seen in Fig.  11, within 4 rain a  100-fold molar excess of unlabeled 
univalent  ligand  (DNP-EACA)  completely  displaced  labeled  DNP-EACA 
bound specifically to MOPC  315  cells,  but displaced only 28% of specifically 
bound DNP-BSA conjugate. The relative avidity of the cell  surface receptors 
for DNP conjugates can be evaluated from the molar concentration of DNP- 
EACA required  to displace 50% of the bound DNP  conjugate.  It was found 
that a 5-fold molar excess of unlabeled DNP-EACA was sufficient to displace 
50% of specifically bound  [3H]DNP-EACA within several minutes,  whereas a 
500-fold excess was required  to displace 50%  of the  specifically bound  [125I]- 
O- 
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FIG.  11.  Displacement of  [125I]DNP-BSA  and  [3HJDNP-EACA  from  MOPC  315  cells 
by excess unlabeled univalent ligand. Similar numbers of MOPC 315 or control cells were in- 
cubated with [I~SI]DNP-BSA  (4 X  10  .9  M)  or [~H]DNP-EACA  (8  X  10  -s  M) for  15 min 
at 27°C, and unlabeled DNP-EACA added to a final concentration of 8 X  10  -6 M. The quan- 
tity  of labeled  conjugate remaining specifically bound  to  the washed cell pellet  was deter- 
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DNP-BSA. Based upon such determinations, the avidity of cell surface Ig for 
[I~aI]DNP-BSA  is approximately 100 times greater than for [~H]DNP-EACA. 
DISCUSSION 
The main findings of this study are (a) DNP conjugates are bound specifically 
by cells of the murine myeloma MOPC 315; and (b) the avidity of cell surface 
Ig  for multivalent  conjugates is  significantly greater than  for the univalent 
compound as shown by direct measurements of association constants. 
Our experiments indicate that under identical conditions, MOPC  315  cells 
bound up to eight times more [I~5I]DNP-BSA  than did similar numbers of con- 
trol murine myeloma cells (P3K, LPC 1, HP 76).  Binding occurred by way of 
the DNP groups interacting with cell surface Ig. This was established by the 
specific inhibition of DNP-BSA binding by (a) DNP-EACA but not BSA, and 
(b)  goat antimouse Ig but not goat antihuman Ig.  Hence, the interaction of 
DNP conjugates to MOPC 315 cells can be regarded as analogous to the bind- 
ing of specific antigen to normal antibody-secreting plasma cells. 
Preliminary studies indicated that MOPC 315 cells bound a univalent con- 
jugate with lower affinity than a  multivalent one. Thus, inclusion of BSA in 
the  medium,  or  extensive washing,  completely inhibited  specific binding  of 
DNP-EACA but not specific binding of DNP-BSA.  Consequently, it proved 
necessary to  establish  different experimental  conditions  for optimal  specific 
binding  of univalent  and  of multivalent  compounds.  When  such  conditions 
were employed, it could be demonstrated directly by measurement of binding 
affinities,  and  indirectly by  inhibition  studies,  that  the  binding  affinity of 
MOPC 315  cells for a  multivalent conjugate was  100-300 times greater than 
for a univalent ligand. 
The  augmentation  in  binding  of multivalent  as  compared with  univalent 
ligands is of similar magnitude to that described by Davie and Paul (9). Their 
approach was to measure the binding of radiolabeled DNP conjugates to lymph 
node cells of immunized guinea pigs. Although the binding of univalent hapten 
could not be directly detected by this procedure, they found that increasing 
the degree of substitution  of DNP-BSA  from 4  to  19 increased by approxi- 
mately 100-fold the molar concentration of DNP-lysine required for 50% inhi- 
bition of binding.  The association constant which we have measured for the 
binding of DNP-BSA to ceils is lower than that reported by Davie and Paul, 
a difference which presumably reflects the low binding affinity of MOPC  315 
protein compared with that of induced antibody (10). 
Theoretical considerations  (11)  and  in  vitro  experiments  (12-16)  indicate 
that there is a marked enhancement of binding as a result of the formation of 
multiple  bonds  between  individual  antigen  and  antibody  molecules.  The 
greater binding  avidity of cells  for multivalent  as  compared with  univalent 
ligands suggests that more than one bond is formed between the protein con- 
jugate and cell surface antibody. While it is not possible from our results to 
determine the actual number of bonds formed, the magnitude of the enhance- J.-C,  BYSTRYN~  G.  W.  SISKIND,  AND  ,]'. W.  UI-IR  313 
ment is of the same order as that reported for univalent as contrasted with 
bivalent interactions of antibody with antigen (16,  17). 
The enhanced binding of multivalent conjugate with cell surface Ig demon- 
strated  in  this  study has  important  biological  implications.  We  previously 
postulated that a dynamic equilibrium between circulating antibody and anti- 
gen in an immunogen-containing compartment regulates the quantity of immu- 
nogen available to stimulate immunocompetent cells  (3).  This concept must 
now be extended to include the interaction of antigen with cell surface receptor 
sites. 
In this context it should be emphasized that the binding of multivalent anti- 
gen to cells may be essentially irreversible under physiological conditions. The 
dissociation of a  complex held by multiple independent bonds  requires  the 
simultaneous rupture of all bonds. The probability of the simultaneous rupture 
of multiple independent bonds is equal to the product of the probabilities of 
the dissociation of the individual bonds.  Consequently, the dissociation of a 
ligand bound by multiple bonds is much less likely than the dissociation of a 
ligand held by a single bond, and may in fact be so slow as to render the reac- 
tion  irreversible  in  practical  terms.  This  stabilization  of  cell-bond  antigen 
through multiple bond formation may have important consequences for the 
process of cell stimulation and selection by antigen. 
Multivalent antigen would be particularly well  suited  (and  may even be 
necessary)  to stimulate immune cells.  There is increasing evidence that pro- 
longed contact of antigen with cells, measured in terms of hours to days, is re- 
quired  for  irreversible  stimulation  (18-21).  Formation  of  multiple  bonds 
between the antigen molecule and cell surface antibody will stabilize the com- 
plex by slowing the dissociation rate and may be especially important in the 
stimulation of low affinity antibody forming cells. Hence, the immunogenicity 
of a compound should increase with increased valence. Several studies suggest 
that this is so (22-24),  within certain limits (25).  Furthermore, antigens com- 
posed of repeating antigenic units should be especially capable of forming stable 
complexes with immunocompetent cells. It is of interest that compounds such 
as bacterial polysaccharides (26,  27),  polyvinylpyrrolidone (26, 28),  and po- 
lymerized flagellin (29) can stimulate B cells directly. 
Cell  surfaces hold specific  receptor  sites  in  multivalent units  so  that  the 
effective valence of the cell surface is greater than that of circulating antibody. 
Though  the  intrinsic  association  constant of  each  individual  cell-associated 
antibody binding site may be identical with that of circulating antibody (30, 
31), the cells, by being able to form multivalent interactions with antigen, have 
an advantage over circulating antibody in binding antigen molecules and re- 
taining them in the bound state. These considerations may explain in part the 
ability of immune cells to bind, retain, and be stimulated by antigen despite 
the unfavorable restrictions imposed by the limited number of cells  and the 
presence of large amounts of circulating antibody shortly after immunization. 
Aggregation of antigen into polyvalent complexes may also account for the 314  BINDING  O~"  ANTIGEN  BY  IMMUNOCYTES 
augmentation of antibody synthesis  (32-36)  and for the in vitro induction  of 
tolerance  (37)  by antibody.  In both instances,  the presence of small amounts 
of antibody could lead to the formation of complexes with a valence higher than 
that of the original antigen  molecule. Thus,  an appropriate quantity of anti- 
body  could  increase  the  proportion  of  antigen  bound  to  immunocompetent 
cells and render the binding effectively irreversible. 
SUMMARY 
The  binding  of  antigen  to  cells  with  antibody  on  their  surface  has  been 
studied  in  a  model  system consisting  of murine  myeloma cells  (MOPC  315) 
and DNP  conjugates.  Specific binding  occurred between  the DNP  groups of 
DNP conjugates and cell  surface immunoglobulin. 
Using  this model, the binding  affinities of multivalent and univalent DNP 
conjugates were measured directly by equilibrium-binding  techniques  and in- 
directly  by  displacement  of  bound  conjugate  with  univalent  hapten.  With 
both approaches the multivalent conjugate was shown to bind to cells with an 
avidity  100-300  fold greater  than  the  univalent  hapten.  Nonspecific binding 
of unrelated protein and repeated washing of cells was found to markedly de- 
decrease the specific binding of univalent  conjugates, presumably because the 
relatively weak bonds dissociate readily. 
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